Showing results (201-210 of 240) with videos related to
Sort By:
Pageof 24
TH Open : Companion Journal to Thrombosis and Haemostasis|September 1, 2022
Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER TrialAlex C Spyropoulos, Mark Goldin, Walter Ageno, et al.Journal of the American Heart Association|October 7, 2022
Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical IllnessGary E Raskob, Walter Ageno, Gregory Albers, et al.Chest|December 3, 2022
Perioperative Management of Vitamin K Antagonists and Direct Oral Anticoagulants: A Systematic Review and Meta-analysisSahrish Shah, Tarek Nayfeh, Bashar Hasan, et al.JACC. Advances|May 13, 2025
Preserving Trial Endpoint Specificity and Cause of Death Attribution in Cardiovascular Trials: Insights From MARINERShea E Hogan, Mario Enrico Canonico, Robert W King, et al.Chest|August 14, 2022
Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice GuidelineJames D Douketis, Alex C Spyropoulos, M Hassan Murad, et al.Journal of Thrombosis and Haemostasis : JTH|October 26, 2024
Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 yearsNeil A Goldenberg, Sam Schulman, John M Kittelson, et al.Journal of Thrombosis and Haemostasis : JTH|July 27, 2021
Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or olderWalter Ageno, Renato D Lopes, Mark Goldin, et al.Circulation|April 7, 2022
Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER TrialsAlex C Spyropoulos, Gary E Raskob, Alexander T Cohen, et al.Pediatrics|April 29, 2022
Enoxaparin Thromboprophylaxis in Children Hospitalized for COVID-19: A Phase 2 TrialAnthony A Sochet, John M Morrison, Julie Jaffray, et al.Journal of Thrombosis and Haemostasis : JTH|June 30, 2015
Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findingsN A Goldenberg, T Abshire, P J Blatchford, et al.Pageof 24